Release of Verilite 2.3.4

Solidsoft Reply has released VeriLite 2.3.4. Our latest update is filled with improvements designed to make reporting simpler and enhance user experience in our lightweight, FMD compliant, cloud-based verification solution.

Deployed in late March 2024, VeriLite 2.3.4 is available to all countries and markets, required by law to use the European Medicines Verification System (EMVS) for pack identifier verification. This latest release further extends support to wholesalers, pharmacists, and doctors across Europe, including our customers in Bulgaria, Cyprus, Denmark, Finland, Iceland, Ireland, Sweden, and Poland. As a reliable and Falsified Medicines Directive (FMD) compliant tool, VeriLite ensures the accurate verification and reporting of medicinal packs bearing unique identifiers. By leveraging the solution, users can make requests to national systems, minimising the risk of falsified medicines entering the supply chain.

You can now enjoy the following VeriLite enhancements:

• Refined Report Lookup: Users can now generate lookup reports within specific timeframes, streamlining the report generation process.
• Improved Access to Reports and Controls: Greater access to reports and better controls over functionalities.
• Enhancements to Application Insights: Significant improvements have been made to the Reporting API, providing more details about the system’s performance.
• Migration of Application Insights: Application Insights are moved to workspace-based setups and connection strings are used instead of the Instrumentation Key. This enhances the system’s reliability and improves overall performance.
• Downloadable User Guide: Users can download the VeriLite user guide directly from the application interface, providing improved user navigation and on-the-go support.
• Seamless Access to Release Notes: Release notes are readily available for download within VeriLite, keeping users up to date about the latest developments.

Pharmacists and wholesalers across Europe are required by law to use the European Medicines Verification System (EMVS) for pack identifier verification. Our VeriLite solution aligns with the EMVS' 'system of systems' approach and contributes to the overall advancement of the pharmaceutical landscape in Europe.

For more information, visit VeriLite or contact us here.

SOLIDSOFT REPLY

Solidsoft Reply is a leading technology company creating award-winning solutions utilising the Microsoft Azure cloud platform. As a globally acclaimed Microsoft AI Cloud Solutions Partner, we specialise in GS1 traceability systems worldwide, crucially ensuring the authenticity, legality, and safety of our customers’ products and services. Serving non-profits, NGOs, healthcare, and the pharmaceutical industries, we deliver technology for positive social impact. Your products, safe in our hands.